Search

Your search keyword '"Elkrief A"' showing total 123 results

Search Constraints

Start Over You searched for: Author "Elkrief A" Remove constraint Author: "Elkrief A" Database ScienceDirect Remove constraint Database: ScienceDirect
123 results on '"Elkrief A"'

Search Results

1. CRYOVATE: A Pilot Study of Lung Cancer Cryoactivation in Combination With Immunotherapy in Advanced NSCLC

2. State of the Science: The Hierarchical Taxonomy of Psychopathology (HiTOP)

4. Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome

5. Three-Year Overall Survival Outcomes and Correlative Analyses in Patients With NSCLC and High (50%–89%) Versus Very High (≥90%) Programmed Death-Ligand 1 Expression Treated With First-Line Pembrolizumab or Cemiplimab

6. Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies

7. The role and evolution of partial splenic embolization over three decades: A multicentric retrospective single cohort study of 90 patients from French nationwide experience

8. Expert opinion on bleeding risk from invasive procedures in cirrhosis

9. Legionnaires Disease in Solid Organ Transplant Recipients: A Decade-Long Nationwide Study in France

12. Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune Microenvironment and Immune Checkpoint Inhibitor Efficacy in NSCLC

13. Hepatocyte-derived biomarkers predict liver-related events at 2 years in Child-Pugh class A alcohol-related cirrhosis

14. Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis

15. Combination Therapy With MDM2 and MEK Inhibitors Is Effective in Patient-Derived Models of Lung Adenocarcinoma With Concurrent Oncogenic Drivers and MDM2 Amplification

16. Differential effect of cannabis use on opioid agonist treatment outcomes: Exploratory analyses from the OPTIMA study

17. Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC

18. Low alcohol consumption influences outcomes in individuals with alcohol-related compensated cirrhosis in a French multicenter cohort

20. Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRASG12D-mutated non-small-cell lung cancer

21. Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium

23. Venous thrombotic events in patients treated with immune checkpoint inhibitors for non-small cell lung cancer: A retrospective multicentric cohort study

25. Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

26. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

30. Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure

31. Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non–small cell lung cancer: A real-world multicentre study

32. High mortality among hospital-acquired COVID-19 infection in patients with cancer: A multicentre observational cohort study

33. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

36. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

37. Efficacy of immune checkpoint inhibitors in older patients with non-small cell lung cancer: Real-world data from multicentric cohorts in Canada and France

39. Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide

40. Effects of Long-term Norfloxacin Therapy in Patients With Advanced Cirrhosis

41. LBP-026 The global prospective observational study to evaluate the role of ‘liver transplantation in patients with cirrhosis and severe acuteon-chronic liver failure (CHANCE)’: study design, demographics and overall outcome

42. Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study

43. OP-4 DEVELOPMENT AND EXTERNAL VALIDATION OF A MODEL TO PREDICT MULTI-DRUG RESISTANT BACTERIAL INFECTIONS IN PATIENTS WITH CIRRHOSIS

46. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure

47. P4.11E.17 Clinical Outcomes and Immunotherapy Retreatment in Patients with Metastatic NSCLC Who Complete at Least Two Years of Immune Checkpoint Blockade

50. Gene- and exon-expression profiling reveals an extensive LPS-induced response in immune cells in patients with cirrhosis

Catalog

Books, media, physical & digital resources